Biogen (BIIB)

Cost of Revenue

$1.18B

Quarterly · Period ending: · USD

BIIB logo

BIIB Cost of Revenue

Latest reported$1.18B
BIIB Quarterly Cost of Revenue ($0.00 → $1.18B)
High-resolution chart · PNG

BIIB cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,178,600,000
661,000,000
496,300,000
876,600,000
946,200,000
577,900,000
583,500,000
638,700,000
955,800,000
498,100,000
618,300,000
659,600,000
592,700,000
662,800,000
570,900,000
469,500,000
484,000,000
753,900,000
660,100,000
511,800,000
459,700,000
478,100,000
490,600,000
449,100,000
411,100,000
454,300,000
447,100,000
430,000,000
476,300,000
602,000,000
488,500,000
460,800,000
421,000,000
446,000,000
509,200,000
370,000,000
366,200,000
384,600,000
326,100,000
416,900,000
370,300,000
313,000,000
331,800,000
310,000,000
286,100,000
312,400,000
297,229,000
302,639,000
291,887,000
279,245,000
258,553,000
234,696,000
230,728,000
133,749,000
133,828,000
139,358,000
139,112,000
133,197,000
139,637,000
123,527,000
100,503,000
103,113,000
100,304,000
95,918,000
106,985,000
97,055,000
99,700,000
93,486,000
90,721,000
98,197,000
101,161,000
107,493,000
92,401,000
100,934,000
87,566,000
81,613,000
84,063,000
81,950,000
62,103,000
66,792,000
77,993,000
67,494,000
113,352,000
89,561,000
71,093,000
99,609,000
83,364,000
64,460,000
151,729,000
254,767,000
138,563,000
639,000
3,791,000
852,000
42,582,000
42,050,000
36,209,000
39,318,000
35,704,000
36,458,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.